Vincerx Pharma Enters Material Definitive Agreement

Ticker: VINC · Form: 8-K · Filed: Mar 18, 2025 · CIK: 1796129

Vincerx Pharma, Inc. 8-K Filing Summary
FieldDetail
CompanyVincerx Pharma, Inc. (VINC)
Form Type8-K
Filed DateMar 18, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, company-name-change

TL;DR

Vincerx Pharma just signed a big deal, could be huge.

AI Summary

On March 14, 2025, Vincerx Pharma, Inc. entered into a Material Definitive Agreement. The company, formerly known as LifeSci Acquisition Corp. and Vincera Pharma, Inc., is a pharmaceutical preparations company based in Palo Alto, California.

Why It Matters

This filing indicates a significant development for Vincerx Pharma, potentially involving a new partnership, acquisition, or licensing deal that could impact its future operations and stock value.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce significant opportunities or risks depending on the nature of the agreement, which is not fully detailed in this initial filing.

Key Players & Entities

  • Vincerx Pharma, Inc. (company) — Registrant
  • LifeSci Acquisition Corp. (company) — Former company name
  • Vincera Pharma, Inc. (company) — Former company name
  • March 14, 2025 (date) — Date of earliest event reported

FAQ

What is the nature of the Material Definitive Agreement entered into by Vincerx Pharma, Inc. on March 14, 2025?

The filing does not specify the details of the Material Definitive Agreement, only that one was entered into on March 14, 2025.

What were the former names of Vincerx Pharma, Inc.?

Vincerx Pharma, Inc. was formerly known as Vincera Pharma, Inc. and LifeSci Acquisition Corp.

When was the name change from LifeSci Acquisition Corp. to Vincera Pharma, Inc.?

The name change from LifeSci Acquisition Corp. occurred on December 6, 2019.

When was the name change from Vincera Pharma, Inc. to Vincerx Pharma, Inc.?

The name change from Vincera Pharma, Inc. occurred on December 23, 2020.

What is Vincerx Pharma, Inc.'s principal executive office address?

Vincerx Pharma, Inc.'s principal executive offices are located at 1825 S. Grant Street, San Mateo, California 94402.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 18, 2025 regarding Vincerx Pharma, Inc. (VINC).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.